Paralos Bioscience
Los Angeles, US · Founded 2024 · Delaware corporation
Founders & leadership
YY
Yanxi YangExecutive
IC
Irene ChenNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$646.9K disclosed across 1 round · 2025
▶$646.9KraisedJun 2026 · 5 investors · BiotechnologyRule 506(b)
▶$646.9KraisedJun 2026 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Irene ChenExecutive Officer, Director
- Yanxi YangExecutive Officer
- Offering amount
- $1M
- Amount sold
- $646.9K
- Minimum investment
- $5K
- Proceeds to insiders
- $140K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Paralos Bioscience raised?
- Paralos Bioscience has disclosed $646.9K raised across 1 round.
- Where is Paralos Bioscience headquartered?
- Paralos Bioscience is headquartered in Los Angeles, US.